One arm, two shots: study tests combo COVID-Flu vaccination
NCT ID NCT06831786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study involved 36 healthy Thai adults to see if getting a COVID-19 booster and flu vaccine together is as effective and safe as getting them separately. Researchers measured immune responses and side effects over one month. The goal was to gather information to potentially simplify future vaccination schedules.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
36 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Thai adults aged 18-60 years, who have vaccinated COVID-19 and influenza vaccine more than 6 months. * The subjects are able to and willing to comply with the requirements of the clinical trial program and could complete the 1-month follow-up of the study. * Individuals who are in good health condition at the time of entry into the trial as determined by medical history, physical examination and clinical judgment of the investigator and meet the requirements of immunization. * The subject can provide with informed consent and sign informed consent form (ICF). Exclusion Criteria: * Have history of influenza or COVID-19 infection within 6 months. * Have the medical history or family history of convulsion, epilepsy, encephalopathy, and psychosis. * Be allergic to any component of the research vaccines or used to have a history of hypersensitivity or serious reactions to vaccination. * History of Guillain-Barré syndrome. * Women with positive urine pregnancy test, pregnant or breast-feeding, or have a pregnancy plan within six months of after baseline period. * Have infectious diseases, including HIV and SARS-CoV-2 infection or any symptom of common cold. * Have history of SARS-CoV-2 infection less than 6 months. * Having severe chronic diseases or condition in progress cannot be controlled. For example, poor controlled DM and uncontrolled HT. * Have the history of urticaria 1 year before receiving the investigational vaccine. * Have known underlying diseases of thrombocytopenia or other coagulation disorders (which may cause contraindications for intramuscular injection). * Having needle sickness. * Have the history of immunosuppressive therapy, cytotoxic therapy, or systemic corticosteroids. * Have received blood products within 4 months before injection of investigational vaccines. * Under anti-tuberculosis treatment. * Not be able to follow the protocol, or not be able to understand the informed consent according to the researcher's judgment, due to various medical, psychological, social, or other conditions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID -19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine, Prince of Songkla University
Songkhla, 90110, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- Can lung ultrasound reveal COVID-19's signature in the lungs?
- When the immune system Can't fight back: tracking three respiratory viruses
- The household maze: how does COVID-19 move between family members?
- Can an oral drug stop COVID-19 from turning deadly?
- Can COVID-19 rapid tests slip into HIV and TB clinics without disrupting care?